[Genetic analysis of a Chinese pedigree affected with branchiootic syndrome due to a nonsense variant of EYA1 gene]

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2022 Apr 10;39(4):374-377. doi: 10.3760/cma.j.cn511374-20201210-00866.
[Article in Chinese]

Abstract

Objective: To analyze the clinical phenotype and genetic basis for a Chinese pedigree suspected for branchiootic syndrome (BOS).

Methods: The proband was subjected to target-capture high-throughput sequencing to detect potential variant of deafness-associated genes. Candidate variants were verified by Sanger sequencing of the family members.

Results: The proband was found to harbor a c.1627C>T (p.Gln543Ter) nonsense variant of the EYA1 gene. Sanger sequencing confirmed that all of the 4 patients with the BOS phenotype from the pedigree have harbored the same heterozygous variant. Based on the guidelines of the American College of Medical Genetics and Genomics, the variant was predicted to be pathogenic (PVS1+PS+PP3+PP4).

Conclusion: The c.1627C>T (p.Gln543Ter) variant of the EYA1 gene probably underlay the BOS phenotype in this pedigree. Above finding has provided a basis for its clinical diagnosis.

MeSH terms

  • Branchio-Oto-Renal Syndrome*
  • China
  • Humans
  • Intracellular Signaling Peptides and Proteins / genetics
  • Mutation
  • Nuclear Proteins / genetics
  • Pedigree
  • Protein Tyrosine Phosphatases / genetics

Substances

  • Intracellular Signaling Peptides and Proteins
  • Nuclear Proteins
  • EYA1 protein, human
  • Protein Tyrosine Phosphatases

Supplementary concepts

  • Branchiootic syndrome